Clinical Research Directory
Browse clinical research sites, groups, and studies.
Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness
Sponsor: Ain Shams University
Summary
This study aimed to evaluate the impact of febuxostat on both carotid intima-media thickness and disease progression in individuals with chronic kidney disease
Official title: Impact of Febuxostat on Disease Progression and Carotid Intima-Media Thickness in Patients With Chronic Kidney Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-05-24
Completion Date
2024-08-24
Last Updated
2026-07-29
Healthy Volunteers
No
Conditions
Interventions
Febuxostat 40 mg
Febuxostat will be given daily for 12 weeks The prescribed dosage was 40 mg taken once daily, self-administered by the patients in addition to their standard treatment.
Locations (1)
Ain Shams University
Cairo, Egypt, Egypt